2 completed, 1 suspended. 1 Early Phase 1, 1 Not applicable, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Suspended 1 |
| Not applicable | 1 | Completed 1 |
| Phase 1 | 1 | Completed 1 |
Follow PBA: new trials by email Literature Review of PBA trials Research Report on PBA
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PBA Use for Treatment of ATF6-/- Patients PBA - ACHROMATOPSIA 7, Achromatopsia | Early Phase 1 | Suspended | Columbia University | 2 | 2025-04-08 | 2026-09-11 |
| Safety and Tolerability of Phenylbutyrate in Inclusion Body Myositis Phenylbutyrate Oral Tablet - Inclusion Body Myositis, Sporadic Inclusion Body Myositis | Phase 1 | Completed | University of Kansas Medical Center | 10 | 2020-08-20 | 2024-09-19 |
| Effect of Endoplasmic Reticulum Stress on Metabolic Function tauroursodeoxycholic acid, placebo, sodium phenylbutyrate - Insulin Resistance, Diabetes | Not applicable | Completed | Washington University School of Medicine | 101 | 2008-02-01 | 2018-05-29 |
Color Vision Defects (1) · Diabetes Mellitus (1) · Diabetes Mellitus, Type 2 (1) · Insulin Resistance (1) · Myositis, Inclusion Body (1) · Obesity (1)
Columbia University (1) · University of Kansas Medical Center (1) · Washington University School of Medicine (1)
United States (3)
Duaa Jabari, MD (1) · Samuel Klein, MD (1) · Stephen Tsang, MD (1)